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Abstract
Background:  Cyclic Vomiting Syndrome (CVS) is a disorder characterized by recurrent,
stereotypic episodes of incapacitating nausea, vomiting and other symptoms, separated by intervals
of comparative wellness. This report describes the clinical features, co-morbidities and problems
encountered in management of 41 adult patients who met the diagnostic criteria for CVS.
Methods: This is a retrospective study of adults with CVS seen between 1994 and 2003. Follow-
up data were obtained by mailed questionnaires.
Results: Age of onset ranged from 2 to 49 years. The duration of CVS at the time of consultation
ranged from less than 1 year to 49 years. CVS episodes were stereotypic in respect of their hours
of onset, symptomatology and length. Ninety-three percent of patients had recognizable
prodromes. Half of the patients experienced a constellation of symptoms consisting of CVS
episodes, migraine diathesis, inter-episodic dyspeptic nausea and a history of panic attacks.
Deterioration in the course of CVS is indicated by coalescence of episodes in time. The prognosis
of CVS is favorable in the majority of patients.
Conclusion: CVS is a disabling disorder affecting adults as well as children. Because its occurrence
in adults is little known, patients experience delayed or mis-diagnosis and ineffectual, sometimes
inappropriately invasive management.
Background
Cyclic Vomiting Syndrome (CVS) consists of recurrent,
stereotypic episodes of incapacitating nausea and vomit-
ing lasting hours to days and separated by symptom-free
intervals, which typically last weeks or months [1-5].
The illness has four phases [6]: the inter-episodic phase, dur-
ing which the patient is relatively symptom-free; the pro-
drome, which begins when the patient begins to sense the
approach of an episode, has nausea of varying intensity,
but is still able to retain oral medications; the emetic phase,
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characterized by intense, persistent nausea, vomiting and
other symptoms; and the recovery phase, which begins with
the subsidence of nausea and ends when hunger, toler-
ance of oral intake and vigor return to normal (Figure 1).
Episodes typically recur 6–12 times per year [1,3]. CVS is
considered to be a functional disorder [7]. Some investi-
gators have suggested that it is a manifestation of migraine
diathesis [1,8-10].
CVS was first described in the English literature in 1882 by
Samuel Gee who reported a series of nine children ranging
in age from 4 to 8 years [10]. Thereafter, CVS was consid-
ered to be a pediatric disorder, and the absence of charac-
teristic physical, laboratory or radiological markers for
CVS resulted in its poor recognition by physicians who
practice adult medicine. Cyclic Vomiting Syndrome has
been reported in adults with onset ranging from child-
hood to middle age [12-14]. CVS in adults has been char-
acterized as similar to CVS in children [15]. However,
naturalistic observation of patients with CVS made during
personalized continuity of care indicates that adults often
present features and management challenges not typical
of pediatric patients. Moreover, the impression is gained
that the pattern of episodes in untreated CVS tends to
remain more or less constant with respect to inter-epi-
sodic duration, duration of the emetic phase and associ-
ated symptoms[15]. By contrast, we found, and herein
describe, the phenomenon of episode coalescence, which
characterizes deterioration in the course of the illness.
Although the high prevalence of migraine diathesis has
been noted for more than 70 years [16], co-morbid anxi-
ety, panic attacks and inter-episodic dyspeptic nausea are
additional features of CVS in many adult patients. These
features of CVS and their possible synergy in cyclic vomit-
ing attacks have not been addressed previously.
We present a retrospective study of 41 consecutive adult
patients selected from a cohort of 237 children and adults
with CVS. Our purpose is to improve recognition of this
frequently missed diagnosis by further describing the fea-
tures of the disorder, the characteristics of patients
afflicted with it, and problems encountered in its manage-
ment.
Methods
Forty-one adult patients were seen by one of us (DRF)
between 1994 and 2003 with complaints compatible with
the diagnostic criteria for CVS, namely, recurrent, self-lim-
ited, stereotypic episodes of intractable nausea and vom-
iting with no identifiable organic cause, separated by
intervals of comparative well-being [2]. Clinical data were
recorded on a standardized form to facilitate later retro-
spective analysis. Three hours were scheduled for each
patient so that his/her illness, including psychological,
social and developmental histories, could be explored
phenomenologically [17] within the framework of the
Schematic representation of the four phases of Cyclic Vomiting Syndrome and their therapeutic goals Figure 1
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bio-psycho-social model of clinical practice [7,18-20].
Each patient was physically examined and a plan of man-
agement was negotiated [21-23]. Data for this report were
extracted from patients' charts, which in some cases were
insufficient for analysis of every feature described in our
results; therefore, the sizes of databases from which statis-
tics were derived vary. Follow-up data were collected by
mailed questionnaires supplemented when necessary by
telephone contact. They contained three questions: "Is
your CVS better, worse or the same as it was at the time of
our initial consultation?", "What made a difference, if
any?", and, "About how many episodes have you had in
the past 12 months and how long have they usually
lasted?".
This study was approved by the Institutional Review
Board of the University of Missouri – Columbia.
Results
Clinical characteristics of the syndrome
Forty-one adults (24 men and 17 women) presented at
between 20 and 64 years of age (average, 34 years;
median, 34 yrs) for evaluation of recurrent vomiting. The
age at onset of the first episode ranged from 2 to 49 years
(mean, 21 yrs; median 20 yrs).
The duration of the CVS at the time of consultation ranged
from less than 1 year to 43 years (mean, 12 yrs; median, 7
yrs.).
The severity of CVS at the time of the consultation was
deemed mild if it did not interfere with patients' ability to
attend work or school; moderate, if employment or
school enrollment were in jeopardy; and severe if the
amount of time they were incapacitated by cyclic vomit-
ing equaled or exceeded the amount of time they were
well. Of 39 patients, 3 had mild, 17 had moderate, and 19
had severe CVS. Seven had been treated in emergency
departments and as in-patients more than 100 times each.
Four patients lost peripheral venous access and required
central venous catheters. Thirteen (32%) were completely
disabled and required financial support.
Stereotypy of episodes
CVS episodes tend to be similar in duration and symp-
tomatology over months or years [1,24]. Eighty-five per-
cent of 39 patients had attacks of fairly uniform length
and 15% had attacks of varying lengths (Figure 2). Typical
hours of onset [1] in 29 patients are depicted in Figure 3.
Most patients' episodes began between midnight and
noon. Seven additional patients included four who
reported "mornings," one who reported "afternoons or
evenings," and two who reported that episodes began at
any time during the day or night. Data were insufficient in
five patients.
Triggering factors
Sixty-three percent of patients (16 men and 10 women)
identified conditions that seemed to trigger the onset of
cyclic vomiting episodes. The most frequent triggers
reported by women were: menstrual periods in 7, noxious
stress in 7, pleasant excitement in 5 and fatigue in 3. The
commonest triggers in men were: noxious stress in 11,
pleasant excitement in 8 and infections in 4.
The prodromal, emetic and recovery phases
The prodrome of a cyclic vomiting episode is important
because it allows for attempts at aborting the emetic
phase. Thirty-eight patients (93%) had recognizable pro-
dromes. The remaining three patients were unable to
identify a prodromal phase because they were already in
the emetic phase when it woke them from sleep. The com-
monest prodromal symptoms in our patients are listed in
descending order of frequency in Table 1.
The emetic phase was characterized by persistence of many
prodromal symptoms plus severe, persistent nausea and
vomiting. The maximum frequency of vomiting and
retching ranged from once every 2 hours to 20 times per
hour (average, 8.5 times per hour). The vomitus often
contained blood and bile. Persistent, often severe abdom-
inal pain occurred in 58% of patients. Low grade fever
(100–102°F) was reported in 10 (25%) and neutrophilia
without band-emia was documented in 9 (22%) of
patients. Tachycardia with hypertension, which devel-
oped during episodes and subsided near the end of the
emetic phase, was recorded in 9 patients.
The intense distress experienced by patients during the
emetic phase of CVS prompted behaviors that were in
some cases mistaken to be psychotic or bulemic. Many
Duration of typical cyclic vomiting episodes in 39 patients Figure 2
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patients who were normally pleasant and cooperative
became irritable, demanding and unable to think clearly
or give an accurate history. Intense thirst (perhaps even
while not dehydrated) was evident in 13 patients. It
prompted sometimes bizarre efforts to access water; in
two hospitalized patients, the interdiction of oral intake
caused them to drink surreptitiously from toilets in the
privacy of their locked bathrooms. Nineteen patients
engaged in "guzzle-and-vomit" behavior. They repeatedly
drank large amounts of liquid and then made themselves
vomit. (One patient disposed of 14 liters in one day.)
Patients reported that filling their stomachs diluted the
irritants in their vomitus and lessened oro-pharyngeal
pain during emesis. They also reported transiently
decreased nausea following rapid evacuation of the stom-
ach and that this self-induced, comfort-seeking maneuver
was easier when the stomach was full rather than empty.
Twenty-three of 41 patients (56%) took prolonged baths
or showers several times a day during cyclic vomiting epi-
sodes. They reported that contact with water lessened the
intensity of nausea, but only while they were in the tub or
shower. The partial relief ceased as soon as they got out of
the water. Hot water was used by all but one patient who
preferred cold water.
The typical length of the recovery phase was reported by 22
patients and ranged from minutes to as much as ten days.
The worsening of Cyclic Vomiting Syndrome
The deterioration of CVS took the form of near- or com-
plete coalescence of episodes. A near-coalescence occurs
when episodes recur with increasing frequency. (The dura-
tion of the increasingly frequent episodes may be the
same, shorter or longer than pre-coalescent episodes.)
Patients who experience complete coalescence are sick
more days than they are well and, in some cases, sick con-
tinuously for weeks at a time. Of 33 patients with episodes
that had been fairly widely spaced, 21 experienced near-
coalescences and six of those went on to have complete
coalescences with persistent nausea and vomiting for as
long as three weeks.
Previous medical records were available for 38 patients.
The accumulated numbers of studies abstracted from
records of our cohort are listed in Table 2. None revealed
organic etiologies for their vomiting.
Sixteen patients underwent 17 surgical attempts to cure
their recurrent vomiting. The procedures are listed in
Table 3. None resulted in improvement.
Characteristics of patients with CVS
CVS is considered to be a manifestation of migraine dia-
thesis [10,25-27]. Of the 40 patients with sufficient data,
28 (70%) experienced migraine headaches during or
between episodes. A diagnostic criterion of migraine is its
familial occurrence [26-28]. Twenty-three (57%) of our
patients had first and/or second-degree relatives with
migraine headache or its variants. Of these, the family his-
tory was matrilineal in 19 (83%), patrilineal in 3 (13%),
indeterminate (sibling only) in 1 (4%) and bilateral in
none (29).
Psychiatric aspects of adult CVS
Clinically significant anxiety is common in children with
CVS [30,31] and seems to be a predisposing factor to
cyclic vomiting episodes [1,16,32-34]. Seven (17%) of our
adult patients reported anticipatory anxiety as being an
important triggering factor. Their fear of the next episode
predisposed the onset of the next episode. The severity of
previous episodes seemed to condition the severity of
their anticipatory anxiety [35].
Histories of physical and/or emotional and/or sexual
abuse during childhood were elicited from 18 (44%) of
our adult patients. Twenty-nine (70%) of our adult
patients had been previously diagnosed with, or had fea-
tures characteristic of, one or more of the following: anxi-
ety disorders, mood disorders, and alcoholism and/or
drug abuse (not including non-recreational use of canna-
bis during episodes).
Symptoms of panic attack were surprisingly prevalent in
adult patients. The criterion for diagnosis of panic attack
[35] is the occurrence of four or more of the thirteen
symptoms listed on the left side of Figure 4. Twenty-eight
(68%) or our adult patients (20 men and 7 women) had
four or more panic symptoms during the prodromal and
The ranges of times of onset of cyclic vomiting episodes in 29  adults who reported typical hours of onset Figure 3
The ranges of times of onset of cyclic vomiting episodes in 29 
adults who reported typical hours of onset. Morning hours 
predominate.BMC Medicine 2005, 3:20 http://www.biomedcentral.com/1741-7015/3/20
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emetic phases of most or all their cyclic vomiting epi-
sodes.
Anxiety and patterns of nausea
Pfau and Li [37] analyzed a series of 106 children with
recurrent vomiting and found two patterns: cyclic and
chronic. The cyclic pattern, exemplified by CVS, consisted
of episodes of continuous nausea and high intensity vom-
iting lasting hours or days and separated by several weeks
of wellness. The chronic pattern, exemplified by the indo-
lent nausea of peptic ulcer or inflammation of the upper
GI tract, consisted of almost daily bouts of low intensity
nausea and vomiting.
By contrast, 26 (63%) of our adult patients had a pattern
of nausea and vomiting that was both cyclic and chronic.
In addition to their cyclic vomiting episodes of high inten-
sity nausea and vomiting, they had low intensity nausea
and abdominal discomfort between episodes that was
indistinguishable from functional dyspepsia [38]. Inter-
episodic dyspeptic nausea occurred on arising in the
morning or other times of the day and was predisposed by
emotional stress or excitement [39-41]. The nausea lasted
from a few minutes to a few hours. It did not always result
in vomiting or prevent going to work or school.
A search for features associated with inter-episodic dys-
peptic nausea showed that it was more common in
patients with migraine diathesis and/or a history of panic
attacks. Almost two-thirds of CVS patients with dyspeptic
nausea had both migraine and panic attacks as co-morbid
features (Figure 5).
Follow-up
Follow-up questionnaires were sent 1 to 10 years after the
initial consultation (average, 4.1 years, median, 3 years).
Of our 41 patients, 37 (90%) responded. Of the 4 non-
responders, one had died of systemic lupus, three could
not be located and one refused to participate.
In answering the first question ("Are your symptoms bet-
ter, worse or the same as when we first consulted?"), 32
(86%) indicated "better," none indicated "worse," and 5
(14%) indicated "the same." The responses to the second
question ("What do you think made a difference?"),
included: use of effective medications (mentioned by 22
patients); having an effective protocol to abort or treat the
emetic phase promptly (9 mentions); learning the diagno-
sis of CVS (9 mentions); a good relationship with a physi-
cian knowledgeable about CVS (8 mentions); learning
how to control "stress" (6 mentions); and six miscellane-
ous responses (having a baby, improved diet, prayer, an
Table 1: Symptoms reported during the prodromal phase of CVS
Number of Patients Reporting Symptoms During Prodrome
23 Nausea
10 Sweating
9 Epigastric pain or "pressure"
9 Fatigue or weakness
8 Feeling hot and/or chilly
6 Cramping urge to defecate
5 Abdominal pain
5 Shivering or shakiness
5 Insomnia or restless, interrupted sleep
4 Aversion for food
4 Pounding or irregular heartbeat
3 Irritability
3 "Panic feelings"
2 Intense thirst
2 Feelings of depersonalization
2 Headache
2 Increased salivation
2D y s p n e a
2 A sensation of abdominal bloating
2 Inability to burp
2 Excessive burping
2 Inability to effect the desired passage of stool or flatus
2 Loose stooling
2 Epigastric burning
1 Paresthesias
1 Light headednessBMC Medicine 2005, 3:20 http://www.biomedcentral.com/1741-7015/3/20
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alternate diagnosis of celiac disease, moving to a less toxic
environment, and "not sure").
Answers to the third question ("About how many epi-
sodes have you had in the past year and how long have
they usually lasted?") allowed for a comparison of each
patient's illness during the year prior to the initial consul-
tation and during the year prior to the follow-up question-
naire, as shown in Figure 6. The intervals between the
initial visits and follow-up ranged from 1 to 10 years, aver-
aging 3.8 years. Otherwise, these data are, at best, semi-
quantitative because they are based on each patient's sub-
jective estimates at two points in time. The data points in
Figure 6 were derived as the products of the number of
attacks and the usual duration of attacks expressed as 24-
hour units of time per year. Sufficient data were available
from 30 patients. By this measure, 27 improved and 3
became worse. The improvement in the 27 ranged from
6.7% to 100%, averaging 84% less time being sick. The
deterioration in 3 ranged from 11% to 119%, averaging
70% more time being sick. (A 4th patient whose illness
had deteriorated was omitted from Figure 6 because he
had developed a persistently coalescent pattern of symp-
toms caused by panic disorder, which had become refrac-
tory to psychiatric management. Therefore, the
deterioration was severe, but not readily quantifiable.)
Discussion
The pattern of nausea and vomiting in CVS is unmistaka-
bly different from other vomiting disorders. Rumination
and bulimia are accompanied by little or no nausea. The
nausea related to reflux disease or achalasia is compara-
tively mild and transient. By contrast, the nausea of a
cyclic vomiting episode is accompanied by dramatic auto-
nomic dysfunction, diminished muscle tone and altered
mental state causing total incapacitation that persists for
the duration of the emetic phase.
The pathogenesis of cyclic vomiting episodes is obscure;
their signs and symptoms mimic other disorders. For
example, vomiting, abdominal pain, stress-induced neu-
trophilia [42] and elevated serum amylase of salivary ori-
gin may mimic pancreatitis, peptic ulcer, appendicitis or
pyelonephritis. Nausea of any etiology [43-45] may cause
myoelectrical abnormalities and delayed gastric emptying
suggestive of organic gastroparesis. The periodicity of
recurrences, with or without hypertension, mimics por-
phyria, pheochromocytoma, abdominal epilepsy, inter-
mittent small bowel obstruction or endometriosis. The
presence of gallstones or the finding of impaired gallblad-
der emptying [46] in patients whose cyclic vomiting epi-
sodes feature nausea, vomiting and epigastric pain, had
prompted cholecystectomies that failed to relieve cyclic
vomiting symptoms [14]. Although many organic dis-
eases present a cyclic or recurrent pattern of vomiting [47],
the Cyclic Vomiting Syndrome is, by definition, primarily
Table 2: Previous diagnostic studies reported in 41 adults with CVS
Diagnostic Study Number
Esophago-Gastro-Duodenoscopies 62
Upper GI barium studies (with or without small bowel follow through) 44
Abdominal/pelvic ultrasonographies 43
Abdominal CT scans 33
Colonoscopies 24
Radionuclide Gastric Emptying Study 20
Urine porphyrins 16
Barium enemas 13
Hepatobiliary scans 10
H. pylori antibody assays 10
Cranial MRI's 9
Laparoscopies 5
Sinus radiographies 2
Endoscopic Retrograde Cholangio-Pancreatographies 1
Urine organic acid assays 1
Total studies indicative of organic etiologies for cyclic vomiting 0
Table 3: Previous surgeries to relieve CVS in 41 adults
Surgical Procedures Number
Cholecystectomies 10
Appendectomies 2
Exploratory laparotomy 1
Pyloroplasty 1
Gastrostomy and jejunostomy 1
Fundoplication 1
Hysterectomy 1
Successful results 0BMC Medicine 2005, 3:20 http://www.biomedcentral.com/1741-7015/3/20
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a disorder of function which appears to originate in the
central nervous system, not the abdomen [10,41,48].
The significance of panic attacks in adults with CVS
Pediatric patients with CVS have higher rates of anxiety
than children generally [1,10]. Panic disorder is uncom-
mon in pre-adolescent children [49], but the emotional
traumas that cause childhood anxiety have also been
experienced during the childhoods of many adult patients
who, by virtue of their longevity, may have lived long
enough for panic to have evolved [50,51].
Conditions that are co-morbid with migraine include
mood disorders, panic disorder and irritable bowel syn-
drome [52-57]. The psycho-social histories in about half
of our cohort suggest that conditions co-morbid with
migraine are likely to be found in adults with CVS when
studied prospectively. Such studies may also show that the
nausea experienced between episodes by 63% of our
cohort is a psycho-physiological reaction to persistent
anxiety [43].
Panic attacks, which can occur in patients with panic dis-
order as well as other anxiety disorders, usually last 5 to 20
minutes [58]. Some CVS patients who are anxious may
experience brief panic attacks during the inter-episodic
phase of their illness. However, in two thirds of our adult
CVS patients, panic attacks triggered cyclic vomiting epi-
sodes during which they not only suffered intense nausea
and vomiting, but also panic symptoms that persisted for
hours or days throughout part or all of their cyclic vomit-
ing episodes. The signs and symptoms of such prolonged
panic often resemble the "adrenergic storm" in patients
with pheochromocytoma during discharges of cata-
cholamines, specifically, diaphoresis, tachycardia, palpi-
tations, hypertension, nausea and vomiting, pallor,
flushing, chest discomfort, abdominal pain and appre-
hensiveness [59]. Stress induces hypothalamic release of
Corticotropin Releasing Factor (CRF) [60]. CRF activates
the locus ceruleus, causing increased adrenergic tone. It
also stimulates inhibitory fibers in the Dorsal Motor
Nucleus of the vagus, thereby suppressing gastric motility,
a concomitant, if not the immediate cause, of nausea
[60,61].
Cyclic Vomiting Syndrome and migraine
The report of a series of 214 children with idiopathic CVS
by Li et al. [10] suggests that pediatric CVS patients can be
subdivided into two groups: migraine-associated CVS
(82%) and non-migraine associated CVS (18%). The first
subgroup had, or subsequently developed, migraine
headaches and/or had family histories of migraine; they
Panic symptoms in 21 men and 7 women during prodromal and emetic phases of cyclic vomiting episodes Figure 4
Panic symptoms in 21 men and 7 women during prodromal and emetic phases of cyclic vomiting episodes. The abrupt onset of 
intense fear or discomfort reaching a peak within 10 minutes, accompanied by four or more of the 13 symptoms listed on the 
left, are the diagnostic criteria for panic attacks [35].BMC Medicine 2005, 3:20 http://www.biomedcentral.com/1741-7015/3/20
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were more likely to benefit from anti-migraine therapy.
The second subgroup had no migrainous features and
responded poorly to anti-migraine drugs. The implication
that could be drawn from this study is that these are dif-
ferent kinds of CVS with different pathogeneses and man-
agements.
Our experience with adult patients suggests an alternative,
less dichotomized hypothesis. There may be at least two
routes to a cyclic vomiting attack. One involves whatever
creates attacks of migraine or migraine equivalents in
patients with migraine diathesesis [29,53,62,64,65]. The
other involves whatever creates anxiety attacks in patients
with anxiety disorders [51,66-73]. The population of CVS
patients might thus be composed of patients who are
"purely" migrainous, devoid of pathological anxiety;
patients with severe anxiety and panic attacks but no
migrainous features; and patients who have elements of
both migraine and anxiety that predispose to cyclic vom-
iting episodes. The efficacy of prophylactic and ameliora-
tive medications might therefore depend on the
appropriateness of the match-up between the therapeutic
agents administered (e.g. anti-migraine, anti-anxiety or
both) and the pathogenic factors in play [52]. Suffice to
say that CVS and/or migraine headaches need to be seen
within the context of their co-morbidities and that
patients with these disorders need to be managed with
their biology, psychology and social milieu in mind
[20,23].
The complication of attack coalescence
The emergence of coalescent patterns of attacks cause
patients and clinicians to fear that CVS is becoming
uncontrollable. A useful hypothesis for the pathogenesis
of coalescence is based on the effects of anxiety and dread.
While some CVS patients suffer pre-morbid anxiety disor-
ders of various kinds that predispose them to nausea, in
others, the disruption of normal development, the inabil-
ity to be gainfully employed or pursue an education, and
Comparison of the cumulative duration of cyclic vomiting  episodes per year at the time of the initial consultation and at  the time of follow-up in 29 patients Figure 6
Comparison of the cumulative duration of cyclic vomiting 
episodes per year at the time of the initial consultation and at 
the time of follow-up in 29 patients. Data points are the 
products of the estimated number of episodes per year mul-
tiplied by the average duration of episodes and are expressed 
as 24-hour units of time. The intervals between initial consul-
tations and follow-up ranged from 1 to 10 years and aver-
aged 3.8 years.
Twenty six CVS patients (63%) experienced dyspeptic nausea  between episodes Figure 5
Twenty six CVS patients (63%) experienced dyspeptic nausea 
between episodes. Dyspeptic patients were more likely to 
have migraine diathesis and/or a history of panic attacks. 
Almost two-thirds of dyspeptic CVS patients had both 
migraine and panic.BMC Medicine 2005, 3:20 http://www.biomedcentral.com/1741-7015/3/20
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the strains that CVS imposes on family life create frustra-
tion, anxiety and depression that is secondary to the bur-
den of illness. Many patients, particularly those whose
episodes are especially painful and long, dread the epi-
sode-to-come so much that the level of autonomic hyper-
activity in the interval between attacks approaches the
level during an actual attack itself. In such cases, the dis-
tinction between cyclic vomiting episodes and interven-
ing periods of wellbeing may become unclear [58].
Management
The concurrence of inter-episodic dyspeptic nausea,
migraine and panic in two-thirds of this cohort of adult
CVS patients suggests that these dysautonomic phenom-
ena share pathways or mechanisms within the central and
autonomic nervous systems [62,63]. The aim of treatment
is to help the patient regain the feeling of being in control
rather than defenseless against recurrences of misery.
Treatment of CVS should be prompt and as minimally
stressful as possible [74]. CVS may take months or dec-
ades to overcome. The patient and physician together
learn what exacerbates and what controls symptoms.
Patients with CVS need a physician who is familiar with
the syndrome, accessible, responsive, collaborative [22],
non-judgmental, caring and has a rational, organized
approach to management [75,76]. Long waits in emer-
gency rooms, encounters with caregivers who are unfamil-
iar with CVS, receiving implausible diagnoses, the
repetition of unrewarding diagnostic procedures, and
stop-gap intravenous hydration followed by being sent
home still sick, are common experiences that reinforce
patients' feelings of being out of control of an illness that
no one understands or can treat. Such experiences seem to
promote coalescent patterns of attacks.
There is as yet no evidence-based treatment of CVS [77].
Although principles of management are helpful, optimal
management for any patient is likely to differ from that of
any other patient [52]. Treatment is applied according to
the phase the patient is in at the time of presentation. The
therapeutic goals during the inter-episodic phase include
migraine  prophylaxis, e.g. amitriptyline [17,78], pro-
pranalol [79], cyproheptadine [78,80] and others [81,82]
if migraine diathesis is suspected. Conditions that pre-dis-
pose to or trigger episodes (e.g. anxiety, chronic infec-
tions, pre-menstrual syndrome [83]) need to be identified
and treated.
The therapeutic goal during the prodromal phase is to
abort the onset of vomiting. To this end, discern the pro-
drome's constituent symptoms and attempt to relieve
each as quickly as possible before vomiting begins. For
example, ondansetron, lorazepam or alprazolam, and
ibuprofen or oxycodone, might be taken for their anti-
nausea, anxiolytic and analgesic effects. If prodromal
symptoms subside as the patient rests, and if the remis-
sion lasts, the emetic phase would have been successfully
aborted.
The therapeutic goals in the emetic phase are the preven-
tion of dehydration, renal insufficiency, electrolyte deple-
tion, tetany, hematemesis, and secretion of inappropriate
anti-diuretic hormone (SIADH) [84,85]. If the emetic
phase cannot be aborted it should be treated without
delay, preferably within an hour of onset. "Watchful wait-
ing" or long waits in treatment facilities are counter-ther-
apeutic. Try to terminate the episode by bolus correction of
dehydration, if it exists, followed by intravenous fluid
maintenance, intravenous H2 receptor blocker or proton
pump inhibitor and intravenous administration of anxio-
lytic and anti-emetic agents. If nausea fails to clear, or if it
subsides only to return within a short time, the only way
to relieve the patient's distress is by sedation, which should
be continued until the emetic phase passes. Deep sleep
stops vomiting that originates in the brain and makes the
patient insensible to nausea and other distress [48]. When
patients know they can get relief promptly, anticipatory
anxiety subsides and, in time, coalescent trends abate
[35]. Preferred sedative drugs are non-addictive and non-
emetogenic. Tachycardia with high blood pressure is
indicative of a hyper-adrenergic state, but tachycardia with
low blood pressure suggests hypovolemia, which should
be corrected before administration of sedative agents with
potential vasodilatory side-effects. Urine specific gravity
determinations can be used for surveillance of possible
SIADH. Hematemesis may be due to prolapse gastropathy
[86,87]. Although hematemesis of this type seldom causes
serious blood loss, it does not preclude bleeding from ero-
sive esophagitis or Mallory-Weiss tears. Intravenous opi-
ates are necessary for pain control in some patients.
However, they should be made aware of opiates' anxio-
lytic effects and the potential for dependence when opi-
ates are used indiscriminately for anxiety as well as
abdominal pain. Symptoms of opiate withdrawal, e.g. irri-
tability, restlessness, nausea, cramps, insomnia, anxiety
[88], may be misinterpreted as those of panic and/or the
prodromal and emetic phases of CVS.
Keep the patient's room dimly lit and quiet. As much as
possible, use brief intervals of spontaneous wakefulness
for measurements of vital signs and urine specimen col-
lections so as to minimize interruptions of sleep. Agita-
tion, water seeking and "guzzle-and-vomit" behaviors are
far better managed with effective sedation than by
attempting to prevent the wakeful patient from engaging
in them.
The recovery phase tends to be prolonged when inade-
quate management of the emetic phase has permitted
severe fluid and electrolyte deficits or weight loss. SomeBMC Medicine 2005, 3:20 http://www.biomedcentral.com/1741-7015/3/20
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patients are able to tolerate a regular diet as soon as their
nausea subsides. Others may suffer a relapse if they take
more than clear liquids initially. Prophylactic medications
should be resumed as soon as the patient is able to do so
comfortably.
Follow-up data suggest that the prognosis for CVS is gen-
erally favorable. Our clinical impression is that the sever-
ity and duration of CVS are influenced by the tractability
of the co-morbidities that predispose to episodes [20].
Although assiduous management of its physical and psy-
chological aspects seems to benefit patients, the relation-
ship between its course and treatment modalities remains
to be clarified by future prospective studies. Such research
will require clear descriptions of the range of clinical fea-
tures of adult CVS, a goal towards which this work aims to
contribute.
Conclusion
CVS affects patients of all ages. CVS is a disorder in which
the patient's emotional wellbeing strongly influences the
success of management. Frustration and despair are in
themselves pathogenic; feelings of optimism and gaining-
control are therapeutic. Pharmacological agents may be
potent, but their efficacy depends to a large extent on the
therapeutic quality of the doctor-patient relationship in
which they are deployed [22,23,89,90].
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